Advances in next-generation sequencing technology and computational data analysis have revolutionized efforts to identify tumor-specific mutant antigens. These altered, potentially immunogenic proteins may prove to be an important target for immunotherapies. In this Cell Press Webinar, Nicholas McGranahan (University College London) and Gerald Linette (University of Pennsylvania) will review progress made and future applications of this important area of cancer immunogenomics.
ご提供いただいた個人情報は、お客様へのサポート、サービス、および販売活動の目的にのみ使用させていただきます。